On Jan. 04, Speers Andrea Carolan divested U.S. $221,965 in shares of Tabula Rasa HealthCare Inc.. The Chief Accounting Officer sold 5,301 shares at a price per share of $41.87. The transaction decreased this specific insider’s holdings to 27,922 shares worth around $1.28 million at present.
The Benchmark Company maintained its Tabula Rasa HealthCare Inc. [TRHC] rating to the equivalent of a Buy but changed the price target to $55 from $65, in a research note dated November 04, 2020. That figure represents around a 16.36% premium from where the company’s shares closed on Wednesday. Other analysts also revised their coverage, with The Benchmark Company’s analysts reiterating the shares to “a Buy” rating in a research note to investors issued in early November. Meanwhile, SunTrust had launched its coverage on TRHC with “Buy”, in a research note produced for clients July 02, 2020. In addition, there was a new coverage from RBC Capital Mkts on April 21, 2020. The research firm rated TRHC “an Outperform”.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Is Tabula Rasa HealthCare Inc. [NASDAQ:TRHC] a Good Buy Right Now?
It should be noted that TRHC technical indicators for short, intermediate as well as long term progress have placed an overall average of 8% as Sell. The average signal changed from 24% Sell in the last week and compares with 88% Sell in the past month. Data from Tabula Rasa HealthCare Inc.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 0.35 million shares in the past 20 days and the short term average signal indicates a Hold. In the last 50 days, the average trading volume was 0.32 million shares while the medium term average advocated for 50% Sell. The average long-term signal stands at Hold and the 100-day average volume stands at 0.31 million shares.
TRHC Price Performance
On Wall Street, Tabula Rasa HealthCare Inc. [NASDAQ:TRHC] finished Wednesday’s session up 3.19% at $46.00. The stock went up to $46.41 at the same session while its lowest single day price was $42.97. In the last five days, it saw a rise of about 10.66%, Tabula Rasa HealthCare Inc. shares gained by almost 7.38% since the beginning of the year. However, the share price has dropped to as low as -34.02% below its one year high. On 01/06/21, the company shares recorded $46.41, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $41.17. The company’s shares have declined by -3.93% in the past year. The 50-day SMA achieved is $37.11 while the 200-day SMA is $48.34. Volume gained to 0.52 million from 0.23 million in the previous session.
TRHC Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 43.84 level, and in case of violation of this particular level, it will cause more drop to 41.69 level. On the upper level, 48.57 is still the key resistance. The stock may increase to the subsequent resistance at 47.28. The Relative Strength Index (RSI) pinned on the 14-day chart is 70.64, implying an overbought technical stance while the MACD stands at 3.16, meaning price will increase in the next trading period. Percent R indicator moved to 3.97%, implying bullish price movement. Stochastic %K at 88.97% suggest selling the stock.
What is the short interest in Tabula Rasa HealthCare Inc.?
Short interest in the Tabula Rasa HealthCare Inc. stock has surged, increasing by 50000.0 shares to total 5.46 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 5.51 million, data from Yahoo Finance shows. The decrease of -0.92% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 29.20% of the overall float for the stock.
Tabula Rasa HealthCare Inc.’s Biggest Shareholders: Who Owns Tabula Rasa HealthCare Inc. [TRHC]?
Filings by BlackRock Fund Advisors showed that the firm now holds a total of 2,863,541 shares or roughly 12.02% of the outstanding TRHC shares. This means their shares have reduced by -44,232 from the 2,863,541 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, Credit Suisse Securities updated stake is worth $48,878,960. Details in the latest 13F filings reveal that Macquarie Investment Management B acquired their 11.67% stake valued at $46,135,427 while The Vanguard Group, Inc. cut theirs at $44,823,535. During the last quarter, Macquarie Investment Management B raised 139,858 of its shares in Tabula Rasa HealthCare Inc. while The Vanguard Group, Inc. sold -16,493 shares. The Artisan Partners LP’s holdings currently number 1,245,107 shares at $57274922.0. According to the firm’s last 13F report, Fred Alger Management LLC shares in the company at filing stood at 1,086,480 shares, roughly $37,440,101.
TRHC Earnings Forecast For The Current Quarter
Tabula Rasa HealthCare Inc. [TRHC] is expected to report weak earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $74.61M and an earnings per share of -$0.08 for Dec 2020. Looking further ahead, the company is expected to report revenue of $81.91M at an EPS of $0.03 for Mar 2021.
TRHC Earnings Estimates For The Current Year
For the financial year, Tabula Rasa HealthCare Inc. [NASDAQ:TRHC] is expected to bring in revenue of $294.76M. The returns are nearly $10.05 million higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 0, lower than that of FY19 by -$0.79. Estimates put this year’s earnings growth at -100.00%, and at an annual 33.00% over the next 5-year period. As for sales, forecasts are for an increase of 3.50% in the current fiscal year and a further 17.70% over the following year.
What are analyst thoughts on Tabula Rasa HealthCare Inc.?
Looking forward to the Tabula Rasa HealthCare Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for Tabula Rasa HealthCare Inc. stock at $41.00 within the next 12 months, which represents almost -12.2 per cent growth from its previous closing price of $46.00. The highest analysts’ target for Tabula Rasa HealthCare Inc. stock projections is $55.00 and the lowest one is $34.00. Still, 11 analysts sharing their consensus rating for TRHC stock in 2021 agree that it is an Overweight.